investor compensation

Rosen Law Firm announces securities class action against Endeavor Group Holdings ($EDR) alleging false merger disclosures. Investors must act before March 18, 2026 lead plaintiff deadline.

Rosen Law Firm files securities class action against $FBRT, alleging false statements about dividend sustainability. Lead plaintiff deadline set for April 27, 2026.

Securities class action filed against VTGN alleges misleading statements about fasedienol drug and PALISADE-3 trial. Investors must act by March 16, 2026 deadline.

Rosen Law Firm files class action against ODDITY Tech (NASDAQ: ODD) for allegedly concealing algorithm changes that boosted customer acquisition costs between February 2025-2026.

Rosen Law Firm urges $PLUG investors to join class action lawsuit by April 3, 2026 deadline alleging false statements about DOE funding.

Securities lawsuit filed against $BYND alleges false statements on asset values. Investors have until March 24 deadline to join class action.

Securities lawsuit filed against $RGNX for allegedly misleading investors about RGX-111 gene therapy efficacy and safety. Lead plaintiff deadline April 14, 2026.

Rosen Law Firm files securities class action against $SLNO for alleged misstatements regarding safety concerns with DCCR drug candidate for Prader-Willi syndrome treatment.

America's Car-Mart stock plunges 18% after reporting unexpected quarterly loss; securities investigation launched over alleged misleading disclosures.

Class action lawsuit filed against $NAAM alleges October 2025 IPO prospectus contained false statements about sales and marketing expenses. Lead plaintiff deadline: April 24, 2026.

Rosen Law Firm pursues class action against Eos Energy Enterprises for alleged false statements about operations and guidance. Investors must act by May 5, 2026 deadline.

Rosen Law Firm files securities class actions against Nektar Therapeutics, Enphase Energy, and Aquestive Therapeutics. Investors have until May 5, 2026 to join.

Rosen Law Firm filed securities class action against Enphase Energy ($ENPH) alleging false statements on inventory and renewable energy credits. Deadline April 20, 2026.

Rosen Law Firm filed class action against Aquestive Therapeutics alleging false statements about product development and regulatory matters. Eligible investors should act before deadline.

REGENXBIO faces securities lawsuit over alleged misleading RGX-111 gene therapy statements. Lead plaintiff deadline is April 14, 2026.

Rosen Law Firm urges $BBWI investors to join class action by March 16, 2026 deadline, alleging materially false statements about business strategy and unmet financial guidance.

Rosen Law Firm alerts $SNOW investors of April 27, 2026 deadline in class action alleging undisclosed negative impacts from product efficiency gains.

Rosen Law Firm sued Richtech Robotics for allegedly misrepresenting a Microsoft partnership. Investors must file claims by April 3, 2026.

Rosen Law Firm files securities class action against Franklin BSP Realty Trust alleging false statements. Investors must act before lead plaintiff deadline.

Rosen Law Firm urges Endeavor Group Holdings investors to secure counsel before March 18 deadline in securities class action over alleged false SEC filings.